Although these results implicate B55α in the positive regulation of angiogenesis, treatment with the small molecule inhibitor of PP2A, LB100, resulted in increased angiogenesis and vascular permeability in hepatocellular carcinoma and pancreatic cancer (88,89). This evidence concerns the gene PTPA and hepatocellular carcinoma.